Clinical trial
Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients…
NCT00135018 · Organisation for Oncology and Translational Research, Other · Completed
Key facts
| NCT number | NCT00135018 |
|---|---|
| Title | Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer |
| Official title | Phase II Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer |
| Lead sponsor | Organisation for Oncology and Translational Research, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | celecoxib and chemotherapy |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | May 1, 2012 |
| First posted | Aug 25, 2005 |
| Last update posted | May 24, 2012 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: